Carolyn Compton gave the plenary talk at the World Congress on Skin Cancer in Edinburgh in September 2014. The talk focuses on the sorry state of biomarker development in the US and globally and the work of the National Biomarker Development Alliance (NBDA) is doing to address the challenges in the system in order to make biomarker development more efficient, effective and successful.